NEWS: July 6th, 2023

July 6th, 2023 was an important and historical day for patients with Alzheimer’s disease and their caregivers. Lecanemab (Leqembi) was given traditional approval by the FDA for the treatment of early stage Alzheimer’s disease, and is the first disease-modifying treatment to be given this type of approval. Lecanemab (Leqembi) reduces beta amyloid plaque burden in the brain (a hallmark of Alzheimer’s disease), and has shown concomitant slowing of the progression of cognitive and functional decline in Alzheimer’s disease.

Furthermore, the Centers for Medicare and Medicaid Services (CMS) will broadly cover the treatment for those who qualify. The logistics are still being worked out, but physicians will need to sign up for a CMS facilitated registry. Patients will need to be enrolled in Medicare, have a diagnosis of mild cognitive impairment or early-stage Alzheimer’s disease, with documented evidence of beta-amyloid plaque in the brain, and have a physician who participates in a qualifying registry. We will be receiving more information in the coming months regarding access to Lecanemab (Leqembi).

We would like to take this time to thank all of the patients and caregivers who have given their time and energy participating in the clinical trials for Lecanemab, and all other clinical trials for the treatment of Alzheimer’s disease. Without the participants, caregivers, and family members, this treatment could not have been approved, so we thank you for your large part in bringing a new treatment for Alzheimer’s disease to the public. As more information is released, we will share it with you.

—————————————————-

About Us

Since, 1987, Clinicians at The Memory Clinic have been providing diagnosis and treatment of memory loss.

• We are located in nearby Bennington, VT
• FDA-approved medications to treat the symptoms of Alzheimer’s disease and other neurocognitive disorders are available.
• Once a diagnosis is made, we offer follow-up testing to monitor the change in cognition and functioning.
• Treatments to slow the progression of Alzheimer’s disease are being tested today in clinical trials. These treatments can be added to most medications including other Alzheimer’s disease medications.
• Participation in clinical trials is always free of charge
• Besides providing the initial new patient evaluation, we offer free memory screens, available Monday-Thursday, please call for availability.

Watch this video to learn more about The Memory Clinic: